On May 13, 2021 Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, reported that management will present at two upcoming virtual investor conferences (Press release, Protara Therapeutics, MAY 13, 2021, View Source [SID1234580020]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Oppenheimer Rare & Orphan Disease Summit on Friday, May 21, 2021 at 11:35am ET

Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 1:30pm ET
A live audio webcast of the presentations can be accessed by visiting the Events and Presentations section of the Company’s website: View Source The webcasts will be archived on the Company’s website for 90 days following the presentation.